Dystrophie musculaire de Duchenne Duchenne muscular dystrophy Animal models of human disease Autophagosome BAR proteins Cavéoles Clathrin Dynamin Core myopathy Disease modifiers Antisense oligonucleotides Cell proliferation Dynamin 2 Myopathie ACTN2 Alpha-actinin-2 Autosomal dominant centronuclear myopathy Amphiphysin Cellular neuroscience Cavins Cross-bridge kinetics Adeno-associated virus vector Ctdnep1 Congenital myopathy Cytoskeleton AD-CNM Satellite cell Biomarkers CAV-3 gene Cancer DMyHC Endocytosis Duchenne muscular dystrophy DMD Biophysics Outflow tract Allele‐specific silencing therapy CTL Nucleus BMP signaling Cytosquelette Dynamin overexpression Cellules de crête neurale Actin nucleus BAF Autophagosome maturation Cross-presentation Allele specific RNA interference Adeno-associated virus AFM Developmental myosin heavy chain Duchenne Muscular Dystrophy Atrial cardiac defects Coeur Cardiotoxin DNM2 Charcot-Marie-Tooth Allele-specific silencing Adeno-Associated virus Dullard Domaine LEM Myopathy Myosin Dynamine Nesprin AAV8 Skeletal muscle Adhesion Muscle Developmental biology Nuclear envelope Diaphragm Allele-specific silencing therapy Cardiomyopathies Caveolins Gene therapy RNA interference Clathrine Atrial heart defects Caveolae Autophagy cellular Dominant centronuclear myopathy Centronuclear myopathy Actin Autophagy Correlative microscopy Cell signaling Dystrophie musculaire d'Emery Dreifuss Cell migration Becker muscular dystrophy BMD Adult patients AAV Mechanotransduction Caveolin Muscular dystrophy Disease heterogeneity Lamin A-type lamins Migration Neural crest cells Skin